Senisca Receives £3.7M Funding to Develop RNA-Based Senotherapeutics
Senisca, an Exeter, UK-based biotechnology company developing RNA-based senotherapeutics to treat age-related disease, recently announced the closing of an additional £3.7M in funding. This round of funding, which brought the total amount raised to £7.1M, saw participation from several notable investors including Emerging Longevity Ventures, QantX, the R42 Group, Trend Investment Group and Apex Ventures, as well as new funds such as Lifespan Vision Ventures. The company plans to utilize the funds to further advance the development of its senotherapeutic programmes, which aim to target the underlying causes of age-related diseases by regulating RNA splicing and reprogramming senescent cells.
Founded as a spinout from the University of Exeter, Senisca is led by CEO Dr Sarah Cole and has established itself as a pioneer in the field of RNA biology.
The company's proprietary technology allows for the selective targeting of RNA splicing dysregulation, a key component of the cellular senescence response, in order to promote cellular reprogramming and mitigate age-related diseases. By focusing on this novel cellular pathway, Senisca's senotherapeutics have demonstrated promising results in various pharmacological and skin health indications, with a direct impact on disease modification in patient-derived models. As the company continues to rapidly evolve, its research and development efforts are centered on generating crucial data for IND submission.
With a mission to transform the landscape of age-related disease treatment, Senisca is at the forefront of innovative biotechnological advancements. By harnessing the power of RNA technology, the company seeks to revolutionize the way in which we approach aging and related health issues. Through strategic partnerships and ongoing research initiatives, Senisca is poised to make a significant impact on the future of healthcare, offering new hope for individuals affected by age-related conditions.
They've invested in Senisca
Get to know these Healthtech investors
| # | Investor | Sector | Stage | Activity | Team | Connect |
|---|---|---|---|---|---|---|
1 |  Emerging Longevity Ventures | 1 investment(s) investment(s) | more info | |||
2 |  QantX | investment(s) investment(s) | more info | |||
3 |  R42 Group | 1 investment(s) investment(s) | more info | |||
4 |  Trend Investment Group | 1 investment(s) investment(s) | more info | |||
5 |  Apex Ventures | 1 investment(s) investment(s) | more info |
Click here for a full list of 6,481+ startup investors in the UK